Streetbeat News

Stock Prices

WKSP

General Motors (GM) and Worksport Ltd (WKSP) have reported positive developments. GM's Q2 results exceeded Wall Street estimates, with revenue and earnings soaring. The automaker also raised its profit guidance for the second time. Worksport received a substantial purchase order for its advanced hard-folding tonneau covers, following a recent order of $720,000 for its soft-folding tonneau covers. Worksport also plans to unveil its SOLIS solar-powered folding tonneau cover by the end of the year.

Portfolio Pulse from Upwallstreet

July 25, 2023 | 1:12 pm

NUE

Nucor Corp (NYSE:NUE) reported a 19% YoY decline in Q2 FY23 net sales to $9.52 billion, missing consensus estimates. The company's EPS fell to $5.81 from $9.67 a year ago, but beat the consensus of $5.53. Nucor repurchased approximately 3.1 million shares at an average price of $147.03 per share in Q2. The company expects Q3 earnings to decrease Q/Q due to decreased profitability, particularly in the steel mills segment.

Portfolio Pulse from Lekha Gupta

July 25, 2023 | 1:12 pm

INPX

Trading of Inpixon (INPX) shares is set to resume at 9:50 a.m. ET.

Portfolio Pulse from Happy Mohamed

July 25, 2023 | 1:10 pm

Unilever Plc (NYSE:UL) reported a 9.1% increase in underlying sales for the first half of FY23, with a 9.4% price increase and a 0.2% volume decline. The company's turnover increased by 2.7% to €30.4 billion. Unilever's underlying operating profit was €5.2 billion, a 3.3% increase from the previous year. The company expects its full-year underlying sales growth to be above 5%, ahead of its multi-year range. UL shares are trading higher by 4.82% at $53.97 in premarket trading.

Portfolio Pulse from Shivani Kumaresan

July 25, 2023 | 1:09 pm

GEHC

GE HealthCare Technologies Inc (NASDAQ:GEHC) reported Q2 FY23 sales of $4.82 billion, up 7% Y/Y and 9% on an organic basis, beating the consensus of $4.79 billion. The company posted an adjusted EPS of $0.92, beating the consensus of $0.87. GE HealthCare raised its FY23 organic revenue growth outlook to 6% - 8% Y/Y from a prior range of 5%-7%. The company forecasts adjusted EPS of $3.70-$3.85 compared to previous guidance of $3.60-$3.75 vs. $3.74 consensus. GEHC shares are up 0.74% $81.23 during the premarket session on the last check Tuesday.

Portfolio Pulse from Vandana Singh

July 25, 2023 | 1:08 pm

FXI

MMM

The Co-CEO of 3M Co has stated in a conference call that the company has observed continued weakness in electronics, consumer retail, and China.

Portfolio Pulse from Happy Mohamed

July 25, 2023 | 1:07 pm

FDX

UPS

FedEx Corp's pilots have rejected a tentative contract deal, leading to renewed negotiations likely under the supervision of the National Mediation Board. The proposed deal included a 30% pay rise and a 30% increase in the pilots' legacy pensions. FedEx's competitor, United Parcel Service Inc, is also preparing to negotiate with its workers to avert a potential strike. FedEx shares closed lower by 0.35% at $258.77 on Monday.

Portfolio Pulse from Akanksha Bakshi

July 25, 2023 | 1:06 pm

AVY

Avery Dennison's shares are trading lower following the company's worse-than-expected Q2 FY23 results and below-consensus Q3 guidance.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 1:06 pm

AMBO

GSUN

HTHT

IRBT

JXJT

KXIN

LVLU

NEGG

NVFY

TRNR

WKSP

YOSH

In Tuesday's pre-market session, several consumer discretionary stocks saw significant movement. Yoshiharu Global, H World Group, Interactive Strength, Kaixin Auto Hldgs, Newegg Commerce, and Worksport saw gains, while Lulus Fashion Lounge, iRobot, Ambow Education Holding, Nova Lifestyle, JX Luxventure, and Golden Sun Education Gr experienced losses.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 1:06 pm

ARAV

BFRG

BLPH

BNOX

BTCY

DRTS

ENZ

HGEN

NMTC

NOVN

STOK

VRAY

During Tuesday's pre-market session, several healthcare stocks experienced significant movements. Bullfrog AI Hldgs, Enzo Biochem, Aravive, Novan, Biotricity, and Alpha Tau Medical saw increases, while Humanigen, NeuroOne Medical Tech, Bellerophon Therapeutics, Stoke Therapeutics, Bionomics, and ViewRay experienced decreases.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 1:05 pm